Results 141 to 150 of about 32,475 (204)

CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells. [PDF]

Cell Death Discov
Khamidullina AI, Yastrebova MA, Bruter AV, Nuzhina JV, Vorobyeva NE, Khrustaleva AM, Varlamova EA, Tyakht AV, Abramenko IE, Ivanova ES, Zamkova MA, Li J, Lim CU, Chen M, Broude EV, Roninson IB, Shtil AA, Tatarskiy VV.   +17 more
europepmc   +1 more source

Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose [PDF]

, 1993
William R. Drobyski, CA Keever, MS Roth, Susanne Koethe, Gerald A. Hanson, Patrick McFadden, JL Gottschall, RC Ash, Peter van Tuinen, MM Horowitz   +9 more
openalex   +1 more source

Bilateral intracochlear hemorrhage: A rare onset of chronic myelogenous leukemia. [PDF]

Clin Case Rep
Flahat B, Bonnard Å, Arebro J.
europepmc   +1 more source

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells. [PDF]

Int J Mol Sci, 2022
Prado-Carrillo O, Arenas-Ramírez A, Llaguno-Munive M, Jurado R, Pérez-Rojas J, Cervera-Ceballos E, Garcia-Lopez P.   +6 more
europepmc   +1 more source

Basophilic crisis of chronic myelogenous leukemia.

, 1989
Michiko Ozaki, Nozomu KANEMITSU, Masaki Yasukawa, Shigeru Fujita   +3 more
openalex   +2 more sources

Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program [PDF]

, 1993
P McGlave, Glenn E. Bartsch, Claudio Anasetti, R Ash, P Beatty, James Gajewski, NA Kernan   +6 more
openalex   +1 more source

Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature. [PDF]

Front Oncol
Xu Y, Fan Y, Liu S, Chang J, Guo C, Chen L, Guo W, Dang J, Wang H, Tan Y.   +9 more
europepmc   +1 more source

COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia. [PDF]

Blood Res, 2022
Kim CS, Kim JY, Choi DR.
europepmc   +1 more source

Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides [PDF]

, 1992
Mariusz Z. Ratajczak, Nobuko Hijiya, Lucia Catani, K DeRiel, S. M. Luger, P. B. Mcglave, AM Gewirtz   +6 more
openalex   +1 more source

The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia. [PDF]

Biophys J, 2022
Liu Y, Jang H, Zhang M, Tsai CJ, Maloney R, Nussinov R.   +5 more
europepmc   +1 more source